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Background: Typhoid fever is caused by Salmonella enterica serotype Typhi (S. typhi). 
Growing communication between Taiwan and neighboring regions in recent years 
could be an important source of typhoid fever. The aim of this study was to analyze 
the clinical characteristics of typhoid fever treated at a medical center in southern 
Taiwan.
Methods: The study group consisted of 33 patients (aged 1−68 years) who had clinical 
symptoms and culture-confirmed typhoid fever. They were studied over a 20-year 
period from January 1987 to December 2006 at a tertiary referral hospital in southern 
Taiwan. Their medical records were reviewed and clinical data were collected.
Results: The study group included 17 males and 16 females. They were divided into 
two groups: group I (≤ 17 years; n = 14) and group II (> 17 years; n = 19). Only one patient 
(7.1%) in group I had a history of travel, compared with 47.4% (n = 9) in group II 
(p = 0.045). Patients in group I also had less chills (group I vs. group II = 7.1% vs. 57.9%, 
p = 0.004). A higher proportion of group I patients had respiratory problems (cough, 
group I vs. group II = 57.1% vs. 26.3%) and a higher proportion of group II patients 
developed complications (group I vs. group II = 14.3% vs. 36.8%), but the differences 
were not significant.
Conclusion: Pediatric patients with typhoid fever in southern Taiwan had less history 
of travel and developed fewer chills than adult patients. Careful examination and 
familiarity with the clinical manifestations are important factors in the early diagnosis 
of typhoid fever.
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1. Introduction
Typhoid fever is caused by Salmonella enterica sero-
type Typhi (S. typhi).1,2 The clinical manifestations 
of typhoid fever are usually nonspecific, and include 
prolonged fever and gastrointestinal symptoms.3,4 
Since humans are the only natural reservoir of 
S. typhi, ingestion of foods or water contaminated 
with human feces or urine is the commonest mode of 
transmission.1,2,5 In developed countries, typhoid 
fever is a sporadic disease that occurs mainly in re-
turning travelers.5 Although the incidence of typhoid 
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fever has decreased markedly, with a few dozen cases 
occurring annually in Taiwan,3 recent increases in 
communication between Taiwan and neighboring 
regions such as South East Asia and China could be 
an important source of typhoid fever.6 Several stud-
ies have reported on typhoid fever in northern, but 
not southern, Taiwan. The aim of this study was to 
analyze the clinical characteristics of typhoid fever 
treated at a medical center in southern Taiwan.
2. Methods
A group of 33 patients (aged 1−68 years) who had 
clinical symptoms and culture-confirmed typhoid 
fever (30 from blood, one from urine, one from bile 
juice, and one from spinal lesion pus) were studied 
over a 20-year period from January 1987 to December 
2006 at a tertiary referral hospital in southern 
Taiwan. Their medical records were reviewed and 
data on age, sex, travel history, symptoms, physical 
signs, laboratory examinations, complications, and 
duration of hospitalization were collected. A positive 
Widal test was defined as a titer of S. typhi O anti-
gen ≥ 1:320, a titer of S. typhi H antigen ≥ 1:640, or 
a four-fold change in titer at follow-up.4 Antimicro-
bial susceptibility was tested using the disk-diffusion 
method and interpreted according to the guidelines 
of the National Committee for Clinical Laboratory 
Standards (NCCLS). Data are presented as mean ± SD. 
χ2 and Fisher’s exact tests were used to evaluate 
the statistical difference between the clinical char-
acteristics and outcomes of the patient groups. The 
Mann-Whitney U test was used to test the difference 
in duration of symptoms, laboratory parameters, 
and hospital stay between the two groups.
3. Results
Typhoid fever is now uncommon in Taiwan, and its 
annual incidence was similar throughout the study 
period. Among the 33 patients with culture-confirmed 
typhoid fever, 17 were males and 16 were females. 
They were divided into two groups: group I (≤ 17 
years; n = 14) and group II (> 17 years; n = 19). Table 1 
compares the clinical symptoms and signs in these 
two groups. Only one patient (7.1%) in group I had a 
history of travel, compared with 47.4% (n = 9) in group 
II (p = 0.045). The main travel regions were South East 
Asia (eight cases) and China (two cases). The aver-
age time from return to Taiwan to symptom onset 
was about 25 days (range, 15−60 days). The symp-
toms and signs of typhoid fever were nonspecific 
(Table 1). The commonest symptom in both groups 
was fever (100% in group I and 89.5% in group II). The 
mean fever duration before admission was 7.6 days 
(range, 1−21 days) in group I and 9.4 days (range, 
0−28 days) in group II. Patients in group II experi-
enced more chills than those in group I (57.9% vs. 
7.1%, p = 0.004). Other common symptoms included 
gastrointestinal tract and respiratory tract problems. 
Table 1 Travel history and clinical manifestations of patients with typhoid fever*
 Age ≤ 17 yr Age > 17 yr p
Sex (M/F) 5M/9F 12M/7F 0.166
Travel history 1 (7.1) 9 (47.4) 0.045†
Symptom/sign
Fever 14 (100) 17 (89.5) 0.496
Fever, mean ± SD (d) 7.6 ± 1.6 9.4 ± 1.7 0.471
Chill 1 (7.1) 11 (57.9) 0.004†
Malaise/ill-looking 1 (7.1) 3 (15.8) 0.620
Headache 2 (14.3) 5 (26.3) 0.670
Cough 8 (57.1) 5 (26.3) 0.148
Rhinorrhea 4 (28.6) 1 (5.3) 0.138
Nausea/vomiting 4 (28.6) 4 (21.1) 0.695
Diarrhea 2 (14.3) 4 (21.1) 1.000
Abdominal pain 5 (35.7) 4 (21.1) 0.442
Body weight loss 1 (7.1) 1 (5.3) 1.000
Genitourinary symptoms‡ 1 (7.1) 3 (15.8) 0.620
Hepatosplenomegaly 3 (21.4) 6 (31.6) 0.698
Jaundice 1 (7.1) 0 (0)
Dizziness 1 (7.1) 1 (5.3)
Neck stiffness 0 (0) 1 (5.3)
*Data are presented as n (%); †p < 0.05; ‡including dysuria and pyuria (n = 1), bilateral flank knocking pain (n = 2), and kidney 
stones (n = 1). M = male; F = female; SD = standard deviation.
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A high proportion of group I patients had cough 
(57.1%) and rhinorrhea (28.6%). These respiratory 
problems might lead to misdiagnosis.
Table 2 compares the laboratory data for the 
two groups. Group I had higher leukocyte counts. 
Leukopenia (< 4000/mm3) was noted in six patients 
(no patients in Group I and six in Group 2). Thrombo-
cytopenia (< 10 × 104/mm3) was noted in three pa-
tients (one in group I and two in group II). C-reactive 
protein (CRP) and erythrocyte sedimentation rate 
were sensitive but not specific markers in both 
groups. Group II had higher CRP levels than group I, 
but the difference was not significant. Blood culture 
was the most common confirmatory test (30/33), 
but cultures were also grown from stool (one pa-
tient), urine (one patient), bile juice (one patient) 
and spinal lesion pus (one patient). Most patients 
received only an initial Widal test, except for one 
patient in group II who had a positive result after 
follow-up 2 weeks later. The initial S. typhi H anti-
gen test was positive in six of 12 patients in group I 
(50%) and three of 10 patients in group II (30%). 
The initial S. typhi O antigen test was positive in 
one of 12 patients in group I (8.3%) and one of 10 
patients in group II (10%).
Typhoid fever can mimic many febrile illnesses, 
leading to diagnostic errors. In our study, typhoid 
fever was the initial diagnosis in only two patients. 
The commonest initial diagnoses were bronchitis 
and bronchopneumonia (eight cases). Urinary tract 
infection was suspected in four patients, and a further 
four patients were diagnosed with fever of unknown 
origin. Other initial diagnoses included: meningitis 
(three cases), sepsis (two cases), dengue fever (two 
cases), colitis (two cases), hepatitis (two cases), in-
fective endocarditis (one case), acute appendicitis 
(one case), juvenile rheumatoid arthritis (one case), 
kidney stones (one case) and gallstones (one case).
Nine patients developed complications. A higher 
proportion of group II patients developed compli-
cations (group I vs. group II = 14.3% vs. 36.8%), but 
the difference was not significant. Two patients in 
group I developed complications, including gastritis 
(one case) and ileus (one case) while seven patients 
in group II developed complications, including hep-
atitis (four cases), pneumonia (one case), acute 
pyelonephritis (one case), and spinal osteomyelitis 
(one case). Hepatitis was defined by raised alanine 
aminotransferase levels, accompanied by hepato-
megaly and clinical jaundice.7,8 The patient who 
developed pneumonia manifested with fever and 
productive cough. Chest X-ray revealed pneumonic 
patches and pleural effusion. No pathogen was iso-
lated from sputum or pleural effusion. The patient 
with acute pyelonephritis presented with fever, 
gross hematuria and bilateral flank knocking pain. 
No pathogen was isolated from urine culture in this 
patient. Both of these patients recovered from their 
illnesses after treatment. A 17-year-old boy, who 
developed osteomyelitis and anterior epidural ab-
scess over the third lumbar spine, manifested with 
fever and back pain. Typhoid fever with complicating 
osteomyelitis was diagnosed when S. typhi was cul-
tured from the spinal lesion. He received anterior 
Table 2 Laboratory data of patients with typhoid fever
 Age ≤ 17 yr Age > 17 yr p
Total leukocytes (/mm3) 8092.9 ± 948.1 5457.9 ± 476.1 0.012*
Segments (%) 60.5 ± 4.3 71.5 ± 2.8 0.038*
Lymphocytes (%) 28.2 ± 4.2 19.0 ± 2.5 0.056
Monocytes (%) 5.9 ± 0.9 4.4 ± 0.8 0.252
Bands (%) 0.9 ± 0.4 2.5 ± 1.3 0.327
Hemoglobin (g/dL) 11.3 ± 0.4 11.9 ± 0.4 0.340
MCV 80.0 ± 1.2 81.0 ± 2.9 0.739
Platelets (×104/mm3) 20.9 ± 2.6 16.3 ± 1.7 0.138
ESR 36.5 ± 9.4 29.5 ± 3.3 0.508
CRP (mg/L) 79.4 ± 13.2 102.8 ± 17.5 0.319
AST (U/L) 176.1 ± 60.1 178.4 ± 27.9 0.968
ALT (U/L) 143.3 ± 25.0 113.0 ± 28.7 0.546
Widal test positive
H antigen  6/12 (50%) 3/10 (30%)
O antigen  1/12 (8.3%) 1/10 (10%)
*p < 0.05. MCV = mean corpuscular volume; ESR = erythrocyte sedimentation rate; CRP = C-reactive protein; AST = aspartate 
aminotransferase; ALT = alanine aminotransferase.
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spinal fusion with iliac bone grafting and intravenous 
ciprofloxacin treatment.
Empirical antibiotics were given according to 
the initial presentations of the 33 patients. After 
a definite diagnosis was made, they were treated 
with appropriate antibiotics including ciprofloxa-
cin (one patient), chloramphenicol (two patients), 
trimethoprim-sulfamethoxazole (three patients), 
ceftriaxone (17 patients), and ampicillin plus gen-
tamicin (11 patients). The duration of antibiotic 
treatment ranged from 7 days to 6 weeks, accord-
ing to the different complications that occurred. 
All of the patients had smooth clinical courses. No 
relapses occurred. There were no differences be-
tween the groups in the duration from admission 
to defervescence (group I vs. group II = 6.79 ± 0.65 
vs. 5.08 ± 0.64 days, p = 0.07), or in the lengths of 
hospitalization (group I vs. group II = 11.07 ± 0.84 vs. 
15.94 ± 3.13 days, p = 0.168).
4. Discussion
In northern Taiwan, typhoid fever occurs more fre-
quently in summer and late autumn,4,5 whereas in our 
study, it occurred mostly in late spring, late autumn 
and even in winter. Similar results were found in 
Vietnam.9 This interesting phenomenon might re-
flect the warmer climate and less marked temper-
ature changes among different seasons in southern 
Taiwan. However, our data are limited, and studies 
involving larger numbers of cases are needed to 
reach a conclusion.
As was found in northern Taiwan, fever was the 
most common symptom of typhoid fever in both age 
groups in southern Taiwan, though typhoid fever in 
children was associated with fewer chills than in 
adults. This difference may be due to poorer ver-
bal reporting by pediatric patients. Gastrointestinal 
symptoms, such as abdominal pain, diarrhea and 
nausea/vomiting, were the second most common 
manifestations of typhoid fever in northern Taiwan,3,4 
whereas respiratory complaints were the second most 
common symptoms in pediatric patients in our study. 
Respiratory symptoms were more common in children 
than in adults, but the difference was not significant. 
The high incidence of respiratory symptoms in chil-
dren suggests that parents should pay more attention 
to the respiratory signs in their febrile children, as 
the unique presentations are responsible for the initial 
impressions and empiric treatments. These respira-
tory problems might, however, lead to misdiagnosis 
due to the lack of other, more specific symptoms.
Elevated transaminases (> 40 U/L) were noted 
in most cases in our series. These data were compat-
ible with the report by Chiu et al,3 but not that by 
Su et al.4 Since elevation of transaminases usually 
resolves after 10−15 days of appropriate treatment,10 
the timing of the test is important. Eosinopenia has 
been reported to be a common and useful marker 
for typhoid fever in children with prolonged fever 
and hepatosplenomegaly,11 but no such manifesta-
tion was found in our study or in other studies in 
Taiwan. In the initial Widal tests, the H antigen had a 
higher positive rate than the O antigen in our study, 
but the low sensitivity and specificity of this test 
limit its clinical usefulness as an initial diagnostic 
test. More reliable serologic tests, such as TyphiDot, 
TUBEX, and polymerase chain reaction, have been 
developed for the diagnosis of typhoid fever.12−14
In developed countries, typhoid fever is usually 
acquired during foreign travel to regions where 
the disease is endemic, or from contact with chronic 
asymptomatic carriers of S. typhi from these areas.15−17 
In our series, we found that the adult group had 
more history of travel than the pediatric group 
(47.4% vs. 7.1%, p = 0.045). Humans are the only 
natural reservoir of S. typhi, which suggests that 
there might have been chronic typhoid carriers 
in the families of the pediatric patients, and suggests 
that more attention should be paid to the family 
history of pediatric patients.
Appropriate antibiotic treatment is important 
in order to cure typhoid fever with minimal com-
plications. The choice of drug and the duration of 
therapy depend on the clinical severity, drug re-
sistance, patient condition, physician experience 
and available resources. The increasing antibiotic 
resistance of S. typhi is a concern. The treatment of 
typhoid fever with older agents such as trimethoprim-
sulfamethoxazole, ampicillin and chloramphenicol 
is associated with relapse rates of 5−15%, whereas 
third-generation cephalosporins, such as azithro-
mycin, and newer quinolones are associated with 
higher cure rates.18−22 The increase in drug resistance 
had been associated with an increase in the severity 
of illness and in complications,1 though this was not 
the case in our series, where only one isolate dem-
onstrated drug resistance. Most of the isolates were 
susceptible to the antibiotics tested (ampicillin, 
chloramphenicol, cotrimoxazole, third-generation 
cephalosporins), except for one strain that was re-
sistant to chloramphenicol. No travel history was 
noted in this patient, who also suffered from hep-
atitis. As with other reports from Taiwan,3,4 drug 
resistance of S. typhi was not a major problem in our 
study. Quinolone-resistant S. typhi has become a 
growing problem in some areas of the world,23,24 and 
in order to avoid the development of resistance to 
quinolones, we suggest that fluoroquinolone should 
be used with caution in Taiwan.
In contrast to some studies in South Asia, which 
suggested that children younger than 5 years old de-
veloped more complications than older patients,25,26 
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all nine patients with complications in this study 
were older than 5 years, a finding consistent with 
the report by Chiu et al.3 Reduced immune responses 
in young children and appropriate early treatment 
might account for this result.
In conclusion, a higher incidence of respiratory 
symptoms and less history of travel may lead to 
incorrect initial diagnoses in pediatric patients with 
typhoid fever. Familiarity with the clinical mani-
festations and a high index of suspicion are very 
important for the early diagnosis of typhoid fever.
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